Plasma-Lyte A
Active substance: SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE
INJECTION, SOLUTION · SODIUM CHLORIDE 526 mg/100mL, SODIUM GLUCONATE 502 mg/100mL, SODIUM ACETATE 368 mg/100mL, POTASSIUM CHLORIDE 37 mg/100mL, MAGNESIUM CHLORIDE 30 mg/100mL
United StatesActive
Marketing holder: Baxter Healthcare Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM CHLORIDE · 526 mg/100mL
- SODIUM GLUCONATE · 502 mg/100mL
- SODIUM ACETATE · 368 mg/100mL
- POTASSIUM CHLORIDE · 37 mg/100mL
- MAGNESIUM CHLORIDE · 30 mg/100mL
Registration
- Registration number
- 0338-0221
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 0338-0221 · Verified 2026-10-09 · open in source